COSMOS Pharmaceutical Corporation
Important Dates
Cosmos Pharmaceutical Corp.'s next confirmed earnings release is scheduled for January 8, 2027.
| Earnings Date | 1/8/2027 |
Share Statistics
As of May 31, 2025, Cosmos Pharmaceutical Corp. has 79.26M shares outstanding.
| Shares Outstanding | 79.26M |
Financial Position
As of May 31, 2025, Cosmos Pharmaceutical Corp. maintains a current ratio of 0.75, meaning it holds 0.8x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 0.75 |
| Quick Ratio | 0.26 |
| Debt / Equity | 19.40 |
Financial Efficiency
These figures cover the twelve months ended May 31, 2025.
| Employee Count | 5,561.25 |
Taxes
USDOver the twelve months ended May 31, 2025, Cosmos Pharmaceutical Corp. recorded 4.73M in income tax expense.
| Income Tax | 4.73M |
Stock Price Statistics
As of the close on September 23, 2026, Cosmos Pharmaceutical Corp.'s stock has declined approximately 34.11% over the past 52 weeks.
| 52-Week Price Change | -34.11% |
Balance Sheet
USDAs of May 31, 2025, Cosmos Pharmaceutical Corp. holds 396.04M in cash and equivalents against 346.87M in total debt, resulting in a net debt position of -98.28M. Total book value stands at 1.79B, with working capital of -382.29M providing operational flexibility.
| Cash & Cash Equivalents | 396.04M |
| Total Debt | 346.87M |
| Net Debt | -98.28M |
| Equity (Book Value) | 1.79B |
| Book Value Per Share | 22.56 |
| Working Capital | -382.29M |
Stock Splits
Cosmos Pharmaceutical Corp.'s most recent stock split took place on August 29, 2024 with a 1:2 split ratio.
| Last Split Date | 8/29/2024 |
| Split Ratio | 1:2 |